Novartis AG NVS
Set alert
159.72 USD -1.80 -1.11%
As of Nov 3, 2:57 PM ET
159.69 Day range 161.77
123.24 52-week range 170.46
- YTD
- +15.85%
- 1 year
- +28.96%
- Open
- 161.31
- Prev close
- 161.52
- Mkt cap
- 301.63B
- Vol
- 738.79K
- Avg vol
- 2.05M
- EPS
- 5.24
- P/E
- 30.48
- Div yield
- 1.91%
More statistics
- Low
- 159.69
- High
- 161.77
- Forward P/E
- 16.25
- Beta
- 0.46
- Short ratio
- 3.01
- Inst. own
- 7.30%
- Dividend
- 4.74
- Ex-div date
- Mar 10, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 148.40
- 200-d avg
- 151.81
- 1y target
- 154.80
1D chart
Signals (54)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | 2:49 PM | 8 minutes ago |
| MACD: Sell Signal | 2:48 PM | 9 minutes ago |
| MACD: Buy Signal | 2:42 PM | 15 minutes ago |
| MACD: Sell Signal | 2:38 PM | 19 minutes ago |
| MACD: Buy Signal | 2:36 PM | 21 minutes ago |
| RSI: Oversold | 2:26 PM | 31 minutes ago |
| MACD: Sell Signal | 2:24 PM | 33 minutes ago |
| MACD: Buy Signal | 2:23 PM | 34 minutes ago |
| SMA: Bearish | 2:07 PM | 50 minutes ago |
| SMA: Bearish | 2:07 PM | 50 minutes ago |
| MACD: Sell Signal | 2:07 PM | 50 minutes ago |
| MACD: Buy Signal | 1:59 PM | 58 minutes ago |
| SMA: Bearish | 1:45 PM | 1 hour ago |
| SMA: Bullish | 1:43 PM | 1 hour ago |
| MACD: Sell Signal | 1:30 PM | 1 hour ago |
| RSI: Overbought | 1:25 PM | 1 hour ago |
| RSI: Overbought | 1:19 PM | 1 hour ago |
| SMA: Bullish | 1:09 PM | 1 hour ago |
| MACD: Buy Signal | 1:04 PM | 1 hour ago |
| RSI: Oversold | 12:59 PM | 1 hour ago |
Newest 20 of 54.
Analyst view
Consensus: hold
Hold
Price target (mean) 154.80 -3.1% downside
Now 159.72
- Target (low)
- 130.00
- Target (mean)
- 154.80
- Target (high)
- 185.00
Ratings (0m) 11 5 buy · 4 hold · 2 sell
- Strong buy3
- Buy2
- Hold4
- Sell1
- Strong sell1
Recommendation trend
- This month 11
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.23 | 2.19 – 2.31 | 2.03 | +9.9% | 14.85B | +7.1% | 3 |
| Next quarter | 2.27 | 2.21 – 2.33 | 1.99 | +14.1% | 14.31B | +5.8% | 2 |
| Current year | 9.16 | 9.01 – 9.38 | 8.98 | +2.0% | 57.38B | +1.3% | 5 |
| Next year | 9.94 | 9.30 – 10.79 | 9.16 | +8.5% | 61.50B | +7.2% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Deutsche Bank | Downgrade | Hold | Sell |
| Sep 10, 2026 | HSBC | Upgrade | Reduce | Hold |
| Mar 26, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 6, 2026 | Barclays | Upgrade | Underweight | Equal-Weight |
| Dec 8, 2025 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 12, 2025 | Goldman Sachs | Downgrade | Neutral | Sell |
| Feb 13, 2025 | UBS | Downgrade | Buy | Neutral |
| Nov 19, 2024 | Erste Group | Downgrade | Buy | Hold |
| Oct 30, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Sep 11, 2024 | B of A Securities | Downgrade | Buy | Neutral |
| Sep 5, 2024 | Goldman Sachs | Downgrade | Buy | Neutral |
| Sep 3, 2024 | Jefferies | Downgrade | Buy | Hold |
| Jul 2, 2024 | Jefferies | Maintained | Buy | Buy |
| Apr 24, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Feb 23, 2024 | BMO Capital | Initiated | — | Market Perform |
| Jan 23, 2024 | Morgan Stanley | Initiated | — | Equal-Weight |
| Sep 25, 2023 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| May 9, 2022 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Dec 6, 2021 | Exane BNP Paribas | Downgrade | Outperform | Neutral |
| Dec 3, 2021 | Bryan Garnier | Downgrade | Buy | Neutral |
| Sep 20, 2021 | Deutsche Bank | Downgrade | Hold | Sell |
| Mar 10, 2021 | Argus Research | Downgrade | Buy | Hold |
| Feb 1, 2021 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Jan 15, 2021 | Deutsche Bank | Initiated | — | Buy |
| Sep 1, 2020 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Feb 25, 2020 | Guggenheim | Downgrade | Buy | Neutral |
| Apr 25, 2019 | Guggenheim | Upgrade | Neutral | Buy |
| Apr 10, 2019 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Nov 26, 2018 | Cowen & Co. | Upgrade | Market Perform | Outperform |
| Nov 19, 2018 | Goldman Sachs | Upgrade | Neutral | Conviction Buy |